Skip to content

Artivion AORT Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Abbott logo
AbbottABT
Edwards Lifesciences logo
Edwards LifesciencesEW
LeMaitre Vascular logo
LeMaitre VascularLMAT
ITG
Integer HoldingsITGR
Merit Medical Systems logo
Merit Medical SystemsMMSI
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-22.7%
Enterprise value$1.27B-25.5%
P/E91.5×
P/S2.3×-1.2×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's operating lease right-of-use assets in other assets?
Artivion (AORT) reported operating lease right-of-use assets in other assets of $34.56M in Q1 2026.
How has Artivion's operating lease right-of-use assets in other assets changed year-over-year?
Artivion's operating lease right-of-use assets in other assets decreased by 11.9% year-over-year, from $39.23M to $34.56M.
What is the long-term trend for Artivion's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Artivion's operating lease right-of-use assets in other assets has grown at a 13.3% compound annual growth rate (CAGR), from $18.57M to $34.7M.